| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 365.43 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Testosterone (TE) is an anabolic androgenic steroid (AAS) that promotes muscle growth and the maintenance of secondary sexual characteristics. Due to its aesthetic benefits, AASs have become popular in sports, typically administered orally or intramuscularly, with doses up to 100 times higher than the therapeutic dose. A
therapeutic dose is safe and sufficient for the desired effect, while a supraphysiological dose is significantly greater than what is needed for normal body functions. Insulin regulates blood glucose levels and metabolic processes. Insulin resistance occurs when cells do not respond well to this hormone, leading to elevated blood sugar levels. It is believed that TE disrupts the secretion of adipocytokines, increases the amount of circulating fatty acids, and may negatively affect insulin signaling in muscle and fat cells. This systematic review aims to understand the influence of administering supraphysiological doses of AASs on blood glucose and insulin levels in male bodybuilding athletes.
Description
This work was supported by FCT/MCTES UIDP/05608/2020, and UIDB/05608/2020 – Health & Technology
Research Center (H&TRC).
Keywords
Glucose Insulin level Anabolic steroids Bodybuilders Men Systematic review FCT_UIDP/05608/2020 FCT_UIDB/05608/2020
Citation
Tavares AS, Bellém F, Ferreira B, Leite B, Calixto C. Impact of supraphysiological doses of anabolic steroids on glucose and insulin levels in male bodybuilders: a systematic review. In: XVII SIEFLAS – Seminário Internacional de Educação Física, Lazer e Saúde, Escola Superior de Educação do Instituto Politécnico de Viana do Castelo, 17 a 19 de outubro de 2024.